Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas

Sponsor
Hillel Yaffe Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00419627
Collaborator
Technion, Israel Institute of Technology (Other)
160
1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the presence of proteins in solid tumors which may lead to an immune response

Detailed Description

The main objective of the study is to evaluate which proteins are presented by the HLA complex of solid tumors. Secondary objectives include to evaluate whether an immune response specific to these proteins has actually been provoked and whether there is a similar immune response following recurrence. Real specimens will be evaluated using PCR and mass spectrometry.

Study Design

Study Type:
Observational
Observational Model:
Natural History
Time Perspective:
Prospective
Official Title:
Proteomic Analysis of Serology and Peptides Presented on the HLA Complex of Breast, Ovarian, Colon, Rectal, Gastric and Pancreatic Adenocarcinoma.
Study Start Date :
Feb 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Patients with adenocarcinoma of breast, colon, rectum, ovary , stomach, pancreas
    Exclusion Criteria:
    • Withdrawal of consent

    • Small specimen which does not allow to retrieve tissue without interfering with pathologic evaluation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hillel Yaffe Medical Center Hadera Israel 38100

    Sponsors and Collaborators

    • Hillel Yaffe Medical Center
    • Technion, Israel Institute of Technology

    Investigators

    • Principal Investigator: Itamar Ashkenazi, M.D., Hillel Yaffe Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00419627
    Other Study ID Numbers:
    • ProtHYMC
    First Posted:
    Jan 8, 2007
    Last Update Posted:
    Jan 8, 2007
    Last Verified:
    Jan 1, 2007

    Study Results

    No Results Posted as of Jan 8, 2007